Identification and therapeutic potential of a vitronectin binding region of meningococcal Msf

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Hill, Darryl J ^a   Griffiths, Natalie J ^a   Borodina, Elena ^a   Andreae, Clio A ^a   Sessions, Richard B ^a   Virji, Mumtaz ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIUM ANTIBODY; MENINGOCOCCAL SURFACE FIBRIL; MENINGOCOCCAL SURFACE FIBRIL ANTIBODY; UNCLASSIFIED DRUG; VITRONECTIN;

AMINO ACID SEQUENCE; ANTIGEN BINDING; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BINDING AFFINITY; CONTROLLED STUDY; MUTATIONAL ANALYSIS; NEISSERIA MENINGITIDIS; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; BINDING SITE; CHEMISTRY; GENETICS; METABOLISM; MOLECULAR GENETICS;

NEISSERIA MENINGITIDIS;

AMINO ACID SEQUENCE; BACTERIAL PROTEINS; BINDING SITES; MOLECULAR SEQUENCE DATA; NEISSERIA MENINGITIDIS; VITRONECTIN;

EID: 84926346452     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0124133     Document Type: Article

References (55)

1. Harrison LH, Trotter CL, Ramsay ME (2009) Global epidemiology of meningococcal disease. Vaccine 27 Suppl 2: B51-63. doi: 10.1016/j.vaccine.2009.04.063 PMID: 19477562
2. Gasparini R, Panatto D (2011) Meningococcal glycoconjugate vaccines. Hum Vaccin 7.
3. Feavers IM, PizzaM (2009) Meningococcal protein antigens and vaccines. Vaccine 27 Suppl 2: B42-50. doi: 10.1016/j.vaccine.2009.05.001 PMID: 19481315
4. Hill DJ, Griffiths NJ, Borodina E, Virji M (2010) Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease. Clin Sci (Lond) 118: 547-564. doi: 10.1042/CS20090513 PMID: 20132098
5. Stephens DS (2009) Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis. Vaccine 27 Suppl 2: B71-77. doi: 10.1016/j.vaccine.2009.04.070 PMID: 19477055
6. Lewis LA, Ngampasutadol J, Wallace R, Reid JE, Vogel U, Ram S (2010) The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement. PLoS Pathog 6: e1001027. doi: 10.1371/journal.ppat.1001027 PMID: 20686663
7. Madico G, Welsch JA, Lewis LA, McNaughton A, Perlman DH, Costello CE, et al. (2006) The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol 177: 501-510. PMID: 16785547
8. Jarva H, Ram S, Vogel U, Blom AM, Meri S (2005) Binding of the complement inhibitor C4bp to serogroup B Neisseria meningitidis. J Immunol 174: 6299-6307. PMID: 15879129
9. Tschopp J, Masson D, Schafer S, Peitsch M, Preissner KT (1988) The heparin binding domain of S-protein/vitronectin binds to complement components C7, C8, and C9 and perforin from cytolytic T-cells and inhibits their lytic activities. Biochemistry 27: 4103-4109. PMID: 2458130
10. Preissner KT, Seiffert D (1998) Role of vitronectin and its receptors in haemostasis and vascular remodeling. Thromb Res 89: 1-21. PMID: 9610756
11. Schvartz I, Seger D, Shaltiel S (1999) Vitronectin. Int J Biochem Cell Biol 31: 539-544. PMID: 10399314
12. Lynn GW, Heller WT, Mayasundari A, Minor KH, Peterson CB (2005) A model for the three-dimensional structure of human plasma vitronectin from small-angle scattering measurements. Biochemistry 44: 565-574. PMID: 15641781
13. Hogasen K, Mollnes TE, Harboe M (1992) Heparin-binding properties of vitronectin are linked to complex formation as illustrated by in vitro polymerization and binding to the terminal complement complex. J Biol Chem 267: 23076-23082. PMID: 1385412
14. Jenne D, Stanley KK (1985) Molecular cloning of S-protein, a link between complement, coagulation and cell-substrate adhesion. EMBO J 4: 3153-3157. PMID: 3004934
15. Preissner KT (1991) Structure and biological role of vitronectin. Annu Rev Cell Biol 7: 275-310. PMID: 1725600
16. Madsen CD, Sidenius N (2008) The interaction between urokinase receptor and vitronectin in cell adhesion and signalling. Eur J Cell Biol 87: 617-629. doi: 10.1016/j.ejcb.2008.02.003 PMID: 18353489
17. Suzuki S, Oldberg A, Hayman EG, Pierschbacher MD, Ruoslahti E (1985) Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin. EMBO J 4: 2519-2524. PMID: 2414098
18. Lane DA, Flynn AM, Pejler G, Lindahl U, Choay J, Preissner K (1987) Structural requirements for the neutralization of heparin-like saccharides by complement S protein/vitronectin. J Biol Chem 262: 16343-16348. PMID: 2445746
19. Liang OD, Rosenblatt S, Chhatwal GS, Preissner KT (1997) Identification of novel heparin-binding domains of vitronectin. FEBS Lett 407: 169-172. PMID: 9166893
20. Singh B, Su YC, Riesbeck K (2010) Vitronectin in bacterial pathogenesis: a host protein used in complement escape and cellular invasion. Mol Microbiol 78: 545-560. doi: 10.1111/j.1365-2958.2010.07373.x PMID: 20807208
21. Sa E Cunha C, Griffiths NJ, Virji M (2010) Neisseria meningitidis Opc invasin binds to the sulphated tyrosines of activated vitronectin to attach to and invade human brain endothelial cells. PLoS Pathog 6: e1000911. doi: 10.1371/journal.ppat.1000911 PMID: 20502634
22. Virji M, Makepeace K, Moxon ER (1994) Distinct mechanisms of interactions of Opc-expressing meningococci at apical and basolateral surfaces of human endothelial-cells - the role of integrins in apical interactions. Mol Microbiol 14: 173-184. PMID: 7530316
23. Griffiths NJ, Sa E Cunha C, Murillo I, Youssef AR, Borodina E, Hill DJ, et al. (2009) Dynamics of Neisseria meningitidis interactions with human cellular barriers and immune effectors. VacciMonitor 18: 88-90.
24. Sjolinder H, Eriksson J, Maudsdotter L, Aro H, Jonsson AB (2008) Meningococcal outer membrane protein NhhA is essential for colonization and disease by preventing phagocytosis and complement attack. Infect Immun 76: 5412-5420. doi: 10.1128/IAI.00478-08 PMID: 18794285
25. Henderson IR, Navarro-Garcia F, Nataro JP (1998) The great escape: structure and function of the autotransporter proteins. Trends Microbiol 6: 370-378. PMID: 9778731
26. Linke D, Riess T, Autenrieth IB, Lupas A, Kempf VA (2006) Trimeric autotransporter adhesins: variable structure, common function. Trends Microbiol 14: 264-270. PMID: 16678419
27. Cotter SE, Yeo HJ, Juehne T, St Geme JW 3rd (2005) Architecture and adhesive activity of the Haemophilus influenzae Hsf adhesin. J Bacteriol 187: 4656-4664. PMID: 15968077
28. Leyton DL, Rossiter AE, Henderson IR (2012) From self sufficiency to dependence: mechanisms and factors important for autotransporter biogenesis. Nat Rev Microbiol 10: 213-225. doi: 10.1038/nrmicro2733 PMID: 22337167
29. Griffiths NJ, Hill DJ, Borodina E, Sessions RB, Devos NI, Feron CM, et al. (2011) Meningococcal surface fibril (Msf) binds to activated vitronectin and inhibits the terminal complement pathway to increase serum resistance. Mol Microbiol 82: 1129-1149. doi: 10.1111/j.1365-2958.2011.07876.x PMID: 22050461
30. Peak IR, Srikhanta Y, Dieckelmann M, Moxon ER, Jennings MP (2000) Identification and characterisation of a novel conserved outer membrane protein from Neisseria meningitidis. FEMS Immunol Med Microbiol 28: 329-334. PMID: 10891657
31. Weynants VE, Feron CM, Goraj KK, Bos MP, Denoel PA, Verlant VG, et al. (2007) Additive and synergistic bactericidal activity of antibodies directed against minor outer membrane proteins of Neisseria meningitidis. Infect Immun 75: 5434-5442. PMID: 17664268
32. St Geme JW 3rd, Cutter D, Barenkamp SJ (1996) Characterization of the genetic locus encoding Haemophilus influenzae type b surface fibrils. J Bacteriol 178: 6281-6287. PMID: 8892830
33. Radin JN, Grass SA, Meng G, Cotter SE, Waksman G, St Geme JW 3rd (2009) Structural basis for the differential binding affinities of the HsfBD1 and HsfBD2 domains in the Haemophilus influenzae Hsf adhesin. J Bacteriol 191: 5068-5075. doi: 10.1128/JB.00395-09 PMID: 19525352
34. Hallstrom T, Trajkovska E, Forsgren A, Riesbeck K (2006) Haemophilus influenzae surface fibrils contribute to serum resistance by interacting with vitronectin. J Immunol 177: 430-436. PMID: 16785539
35. Pohl WR, Conlan MG, Thompson AB, Ertl RF, Romberger DJ, Mosher DF, et al. (1991) Vitronectin in bronchoalveolar lavage fluid is increased in patients with interstitial lung disease. Am Rev Respir Dis 143: 1369-1375. PMID: 1710880
36. Arko RJ, Chen CY, Schalla WO, Sarafian SK, Taylor CL, Knapp JS, et al. (1991) Binding of S protein by Neisseria gonorrhoeae and potential role in invasion. J Clin Microbiol 29: 70-75. PMID: 1704384
37. Bergmann S, Lang A, Rohde M, Agarwal V, Rennemeier C, Grashoff C, et al. (2009) Integrin-linked kinase is required for vitronectin-mediated internalization of Streptococcus pneumoniae by host cells. J Cell Sci 122: 256-267. doi: 10.1242/jcs.035600 PMID: 19118218
38. Duensing TD, van Putten JP (1997) Vitronectin mediates internalization of Neisseria gonorrhoeae by Chinese hamster ovary cells. Infect Immun 65: 964-970. PMID: 9038304
39. Hill DJ, Whittles C, Virji M (2012) A novel group of Moraxella catarrhalis UspA proteins mediates cellular adhesion via CEACAMs and vitronectin. PLoS One 7: e45452. doi: 10.1371/journal.pone.0045452 PMID: 23049802
40. Sa E Cunha C, Griffiths NJ, Murillo I, Virji M (2009) Neisseria meningitidis Opc invasin binds to the cytoskeletal protein alpha-actinin. Cell Microbiol 11: 389-405. doi: 10.1111/j.1462-5822.2008.01262.x PMID: 19016781
41. Hallstrom T, Blom AM, Zipfel PF, Riesbeck K (2009) Nontypeable Haemophilus influenzae protein E binds vitronectin and is important for serum resistance. J Immunol 183: 2593-2601. doi: 10.4049/jimmunol.0803226 PMID: 19635912
42. Su YC, Jalalvand F, Morgelin M, Blom AM, Singh B, Riesbeck K (2013) Haemophilus influenzae acquires vitronectin via the ubiquitous Protein F to subvert host innate immunity. Mol Microbiol 87: 1245-1266. doi: 10.1111/mmi.12164 PMID: 23387957
43. Attia AS, Ram S, Rice PA, Hansen EJ (2006) Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade. Infect Immun 74: 1597-1611. PMID: 16495531
44. Singh B, Blom AM, Unal C, Nilson B, Morgelin M, Riesbeck K (2010) Vitronectin binds to the head region of Moraxella catarrhalis ubiquitous surface protein A2 and confers complement-inhibitory activity. Mol Microbiol 75: 1426-1444. doi: 10.1111/j.1365-2958.2010.07066.x PMID: 20199596
45. Su YC, Hallstrom BM, Bernhard S, Singh B, Riesbeck K (2013) Impact of sequence diversity in the Moraxella catarrhalis UspA2/UspA2H head domain on vitronectin binding and antigenic variation. Microbes Infect 15: 375-387. doi: 10.1016/j.micinf.2013.02.004 PMID: 23474333
46. Attia AS, Lafontaine ER, Latimer JL, Aebi C, Syrogiannopoulos GA, Hansen EJ (2005) The UspA2 protein of Moraxella catarrhalis is directly involved in the expression of serum resistance. Infect Immun 73: 2400-2410. PMID: 15784586
47. Nadel S (2012) Prospects for eradication of meningococcal disease. Arch Dis Child 97: 993-998. doi: 10.1136/archdischild-2012-302036 PMID: 22984187
48. Gorringe AR, Pajon R (2012) Bexsero: a multicomponent vaccine for prevention of meningococcal disease. Hum Vaccin Immunother 8: 174-183. doi: 10.4161/hv.18500 PMID: 22426368
49. Harris SL, Zhu D, Murphy E, McNeil LK, Wang X, Mayer LW, et al. (2011) Preclinical evidence for the potential of a bivalent fHBP vaccine to prevent Neisseria meningitidis Serogroup C Disease. Hum Vaccin 7 Suppl: 68-74. PMID: 21245657
50. Bettinger JA, Scheifele DW, Halperin SA, Vaudry W, Findlow J, Borrow R, et al. (2013) Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB). Vaccine.
51. Vogel U, Taha MK, Vazquez JA, Findlow J, Claus H, Stefanelli P, et al. (2013) Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. Lancet Infect Dis.
52. Jordan PW, Saunders NJ (2009) Host iron binding proteins acting as niche indicators for Neisseria meningitidis. PLoS One 4: e5198. doi: 10.1371/journal.pone.0005198 PMID: 19352437
53. Johnson S, Tan L, van der Veen S, Caesar J, Goicoechea De Jorge E, Harding RJ, et al. (2012) Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen molecules. PLoS Pathog 8: e1002981. doi: 10.1371/journal.ppat.1002981 PMID: 23133374
54. Virji M, Kayhty H, Ferguson DJ, Alexandrescu C, Heckels JE, Moxon ER (1991) The role of pili in the interactions of pathogenic Neisseria with cultured human endothelial cells. Mol Microbiol 5: 1831-1841. PMID: 1722554
55. Zhou A, Huntington JA, Pannu NS, Carrell RW, Read RJ (2003) How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration. Nat Struct Biol 10: 541-544. PMID: 12808446